
Agenda
ASCVD has seen a significant reduction in the recent years. Yet, the disease is a major cause of disability and death both in the United States and globally. Physicians and clinicians must gain the knowledge, skill and resources to integrate the latest research and clinical guidelines in the context of their own practice. At ESCAPE, attendees will hear nationally renowned speakers discuss ACC/AHA guidelines on hypertension, blood cholesterol, women’s heart disease, electrophysiology, interventional cardiology and congestive heart failure.
4:00 pm |
Registration (OMNI Amelia Island Conference Center) |
4:30 pm |
Clinical Cases From Office Based Practice |
5:30 pm |
Challenging Cases in Primary and Secondary CVD Prevention |
7:00 am | REGISTRATION, BREAKFAST AND EXHIBITS |
7:25 am |
WELCOME |
7:30 am |
Very High HDL: Is it a Good Thing? |
7:50 am |
LDL Therapies for High-risk patients who Have Not Achieved Optimal LDL |
8:10 am |
Aspirin Use in Primary Prevention |
8:30 am | PANEL DISCUSSION / Q & A |
8:50 am |
BREAK AND EXHIBITS
|
9:10 am |
DAPT post-PCI in Patients at High Risk for Bleeding |
9:30 am |
Post-COVID complications |
9:50 am |
Home-Based Cardiac Rehab: An option During COVID and Beyond |
10:10 am | PANEL DISCUSSION / Q & A |
10:30 am | BREAK AND EXHIBITS |
10:50 am |
Carotid Artery Disease |
11:10 am |
HOCM: Review of Diagnosis and Treatment |
11:30 am | PANEL DISCUSSION / Q & A |
11:45 am | ADJOURNMENT |
5:45 pm |
ATTENDEE / SPOUSE RECEPTION |
6:30 am | SIGN-IN, EXHIBITS, BREAKFAST |
6:45 am |
EKGS PEARLS WITH THE PROFESSOR |
7:30 am |
Microvascular Disease |
7:50 am |
Management of ASCVD Risk in Patients with Hypertriglyceridemia |
8:10 am |
Addressing the Naturalist Patient: Nutritional Supplements in CVD Prevention |
8:30 am | PANEL DISCUSSION/ Q & A |
8:50 am |
BREAK AND EXHIBITS
|
9:10 am |
Overview of 2019 Cholesterol Guidelines |
9:30 am |
Lifestyle Management for CVD Prevention: How Do I Counsel My Patient? |
9:50 am |
Hypertension Treatment and Control: Implications of Recent Clinical Trials |
10:10 am | PANEL DISCUSSION / Q & A |
10:30 am | BREAK AND EXHIBITS |
10:50 am |
Heart Healthy Dietary Patterns: A Recipe for Life |
11:10 am |
Obesity and the Epidemic of Cardiometabolic Diseases |
11:30 am | PANEL DISCUSSION/ Q &A |
11:45 am | ADJOURMENT |
12:00 pm |
OPTIONAL LUNCH ROUNDTABLE DISCUSSION |
6:00 pm | Family Social & Cookout |
6:30 am |
MEDITATION SESSION - Beach Location TBD |
7:00 am |
SIGN-IN, BREAKFAST AND EXHIBITS |
7:30 am |
Preoperative CV Evaluation: To Stress or Not to Stress |
7:50 am |
Heart Failure Management in a Safety-Net Clinic: The Grady Model of Success |
8:10 am |
Telehealth in CV Care: Is it Here to Stay? |
8:30 am | PANEL DISCUSSION / Q & A |
8:50 am |
BREAK AND EXHIBITS
|
9:10 am |
Evaluation of Syncope |
9:30 am |
Venous Insufficiency: The Other Cause of LE Edema |
9:50 am |
OSA and CVD |
10:10 am | PANEL DISCUSSION / Q & A |
10:30 am | BREAK AND EXHIBITS |
10:50 am |
NAFLD: The Heart of the Matter |
11:10 am |
Mental Stress and Cardiovascular Disease |
11:30 am | PANEL DISCUSSION / Q & A |
11:45 am | ADJOURNMENT |
6:30 am |
SIGN-IN, BREAKFAST AND EXHIBITS |
7:00 am |
Management of Pulmonary Embolism |
7:20 am |
Percutaneous Mitral Valve Therapies: Prevention of Sternotomy |
7:40 am |
Optimization of HF Treatment: Review of the 2021 Expert Consensus Decision Pathway |
8:00 am |
Role of the Clinical Pharmacist in the Outpatient Cardiology Clinic |
8:20 am | PANEL DISCUSSION / Q & A |
8:40 am |
Review of 2021 ACC/AHA Chest Pain Guidelines |
9:00 am |
Diabetes and CVD: Beyond the Coronary Arteries |
9:20 am |
High-Risk PCI: Where are We in 2022? |
9:40 am |
TAVR: From the Low-Risk to the High-Risk Patient |
10:00 am |
Supraventricular Tachycardias: From ECG to Cardiology Referral |
10:20 am |
PANEL DISCUSSION/ Q & A
|
10:45 am | ADJOURMENT |